RNAC
Cartesian Therapeutics, Inc. · Healthcare
Chief Scientific Officer Christopher M Jewell sold $875K of Cartesian Therapeutics, Inc.
Sold$875,042
$16.79Price
52,115Shares
−67%Stake
What RNAC did after the filing
- The stock from Mon, Nov 18 close, $18.57
- −8.8%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 2 close.
Traded Thu, Nov 14. Filed Mon, Nov 18, 2:23 PM ET, during the session. Returns use the Nov 18 close and the Jan 2 close. Not investment advice.